04-23-2020, 02:32 PM
CovidSurg will be a platform of studies aiming to explore the impact of COVID-19 in surgical patients and services.
The WFNS is supporting the @CovidSurg studies and is encouraging all neurosurgeons to participate. To sign up visit https://globalsurg.org/covidsurg/
More info here and on the website:
Outcomes of elective cancer surgery during the COVID-19 pandemic crisis: an international, multicentre, observational cohort study (CovidSurg-Cancer)
Any centre that performs elective cancer surgery and has been affected by COVID-19 is eligible for participation. Investigators may choose one or more cancer types from their centre from which to upload data. This study be performed prospectively, retrospectively or using a mixed model, dependent on the phase of COVID-19 infection in your hospital.
The WFNS is supporting the @CovidSurg studies and is encouraging all neurosurgeons to participate. To sign up visit https://globalsurg.org/covidsurg/
More info here and on the website:
Outcomes of elective cancer surgery during the COVID-19 pandemic crisis: an international, multicentre, observational cohort study (CovidSurg-Cancer)
The rapid emergence of the COVID-19 virus has led to a global impact on elective surgical care. We have very little evidence to guide us. The magnitude and effects of these changes are uncertain. The safety of operating on patients electively with the risks of COVID-19 postoperative pneumonia is unknown. High-quality data will allow policy planning at regional and hospital level for both this outbreak and future pandemics. CovidSurg-Cancer will run in parallel to CovidSurg (which is capturing outcomes of patients undergoing surgery for all indications with concurrent COVID-19).
In order to contribute to CovidSurg-Cancer you must first secure appropriate approvals and senior surgeon leadership, according to local regulations. This short protocol has been written to support that process. This investigator-led, non-commercial, non-interventional study is extremely low to zero risk. This study does not collect any patient identifiable information and data will not be analysed at hospital-level.
Any centre that performs elective cancer surgery and has been affected by COVID-19 is eligible for participation. Investigators may choose one or more cancer types from their centre from which to upload data. This study be performed prospectively, retrospectively or using a mixed model, dependent on the phase of COVID-19 infection in your hospital.